Gene polymorphism of blood coagulation factors and endothelial dysfunction in early and late preeclampsia.

Authors

DOI:

https://doi.org/10.26641/2307-0404.2020.2.206363

Keywords:

pregnancy, pre-eclampsia, obstetric and perinatal complications, gene polymorphism

Abstract

The aim of our study was to find out the influence of gene polymorphisms of coagulation factors, endothelial dysfunction and regulators of blood pressure in early (EPE) and late preeclampsia (LPE). The study of genetic polymorphisms of blood coagulation factors and fibrinolysis (1691 G/A factor V Leiden (FVL), 20210 G/A prothrombin, -675 5G/4G PAI-1, 455 G/A fibrinogen β), endothelial dysfunction (192 Q → R paraoxonase 1, 677 C/T MTHFR, arterial pressure regulator (235 M/T angio­tensinogen II (AGT II)) using an PCR was performed. A prospective cohort study of 39 women with EPE, 93 with LPE and 44 pregnant women with a physiological pregnancy (C group) was conducted. The average gestational age at the time of delivery in EPE group was lower than in LPE and control group (p<0.001). In group with EPE new-borns had low weight-growth characteristics, low grade by the Apgar scale and foetal distress (38.5% vs. 9.7%, p<0.05). Caesarean section in EPE group was performed by 2.25 times more often than in control group and by 2,13 times than in LPE group (p<0,05). It was detected that the number of 1691 GA FVL heterozygote carriers in the group with EPE was significantly higher than in LPE group (p<0.05, OR=3.65, 95% CI 1.5-8.9) and control group (6.04, 1.7-21.6). The number of 20210 GG homozygotes and 20210 GA heterozygotes in prothrombin gene was probably lower in EPE group compared with the LPE and control group (0.03, 0.002-0.49, and 0.18, 0.06-0.53, respectively). It was established increase in frequency of 677 TT MTHFR genotype in EPE compared with control group (17.27; 0.9-317). Also, the carriers of 235T allele AGT II gene have an increased risk of EPE and PPE development (2.25, 1.2-4.2), (1.9, 1.1-3.3) respectively. The allele -455A of fibrinogen β gene increases the chances of developing EPE by 4.4 times (2.0-9.5), and LPE by 3.5 times (1.7-7.1). Risk factors that significantly increase the chances of developing early preeclampsia were identified: allele 1691 A of FV Leiden (5.96, 1.5-8.9), allele 20210 A of prothrombin (39.8, 2,3-679), 677T MTHFR (2.5, 1.18-5.3). In was detected that other researched polymorphisms between groups with PE were not significantly different and did not affect on time of preeclampsia development.

Author Biographies

T. O. Loskutova

SE «Dnipropetrovsk medical academy of Health Ministry of Ukraine»
V. Vernadsky str., 9, Dnipro, 49044, Ukraine

T. V. Demchenko

SE «Dnipropetrovsk medical academy of Health Ministry of Ukraine»
V. Vernadsky str., 9, Dnipro, 49044, Ukraine

N. V. Kryachkova

SE «Dnipropetrovsk medical academy of Health Ministry of Ukraine»
V. Vernadsky str., 9, Dnipro, 49044, Ukraine

References

Loskutova TO. [Polymorphism of genes of hemo­stasis system, endothelial dysfunction and regulation of blood pressure in pregnant woman with preeclampsia and fetal growth retardation]. Pathologia. 2018;1(42):29-34. doi: https://doi.org/10.14739/2310-1237.2018.1.127709

Loskutova T. [Development of complications of gestation in pregnant women with preeclampsia as­sociated with thrombophilia]. Medicni perspektivi. 2016;21(1):64-70. Ukrainian. doi: https://doi.org/10.26641/2307-0404.2016.1.63477

Sonek J, Krantz D, Carmichael J, Downing C, Jessup K, Haidar Z, Ho S, Hallahan T, KlimanH, McKenna D. First-trimester screening for early and late preeclampsia using maternal characteristics, biomarkers, and estimated placental volume. American Journal of Obstetrics and Gynecology. 2018;218(1):126.e1-126.e13. doi: https://doi.org/10.1016/j.ajog.2017.10.024

Lopach SN. [Statistical methods in biomedical research using Excel]. Kyiv: Moryon; 2001. p. 408. Russian.

Andraweera P, Dekker G, Thompson S, Dissa­nayake V, Jayasekara R, Roberts C. Hypoxia-inducible factor-1α gene polymorphisms in early and late onset pre­eclampsia in Sinhalese women. Placenta. 2014;35(7):491-5. doi: https://doi.org/10.1016/j.placenta.2014.04.008

Iacobelli S, Bonsante F, Robillard P. Comparison of risk factors and perinatal outcomes in early onset and late onset preeclampsia: A cohort based study in Reunion Island. Journal of Reproductive Immunology. 2017;123:12-16. doi: https://doi.org/10.1016/j.jri.2017.08.005

Kwok P, Chen X. Detection of Single Nucleotide Polymorphisms. Current Issues in Molecular Biology. 2003;5(2):43-60. doi: https://doi.org/10.21775/cimb.005.043

Redman C. Early and late onset preeclampsia: Two sides of the same coin. Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health. 2017;7:58. doi: https://doi.org/10.1016/j.preghy.2016.10.011

Simcox L, Ormesher L, Tower C, Greer I. Throm­bophilia and Pregnancy Complications. International Journal of Molecular Sciences. 2015;16(12):28418-28. doi: https://dx.doi.org/10.3390/ijms161226104

How to Cite

1.
Loskutova TO, Demchenko TV, Kryachkova NV. Gene polymorphism of blood coagulation factors and endothelial dysfunction in early and late preeclampsia. Med. perspekt. [Internet]. 2020Jul.1 [cited 2024Jun.15];25(2):66-71. Available from: https://journals.uran.ua/index.php/2307-0404/article/view/206363

Issue

Section

CLINICAL MEDICINE